Literature DB >> 28927144

MiR-381 inhibits migration and invasion in human gastric carcinoma through downregulatedting SOX4.

Mingming Zhang1, Shishu Huang2, Dan Long3.   

Abstract

Aberrant expression of microRNAs (miRs) serves essential roles in the generation and progression of various types of human cancer. In the present study, the expression and biological functions of miR-381 in human gastric carcinoma (GC) were focused upon. The results of reverse transcription-quantitative polymerase chain reaction analysis revealed that the expression of miR-381 was significantly downregulated in GC tissue samples. Furthermore, low expression of miR-381 was identified to be associated with lymphatic metastasis and advanced tumor-node-metastasis stage (III+IV). Upregulation of miR-381 inhibited the migration and invasion of GC SGC-7901 cells through SRY-Box 4 (SOX4)-mediated epithelial-mesenchymal transition. Finally, long non-coding (lnc) RNA-taurine upregulatedted 1 (non-protein coding) (TUG1) was confirmed as a negatively regulator of miR-381 expression in SGC-7901 cells. Taken together, the results of the current study indicate that the downregulation of miR-381 by lncRNA-TUG1 promoted the metastasis of GC cells by inhibiting SOX4. Thus, targeting miR-381 may be a novel therapeutic option for the treatment of patients with GC.

Entities:  

Keywords:  SOX4; gastric carcinoma; invasion; miR-381; migration

Year:  2017        PMID: 28927144      PMCID: PMC5588059          DOI: 10.3892/ol.2017.6637

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  24 in total

1.  Identification of several circulating microRNAs from a genome-wide circulating microRNA expression profile as potential biomarkers for impaired glucose metabolism in polycystic ovarian syndrome.

Authors:  Linlin Jiang; Jia Huang; Yaxiao Chen; Yabo Yang; Ruiqi Li; Yu Li; Xiaoli Chen; Dongzi Yang
Journal:  Endocrine       Date:  2016-02-09       Impact factor: 3.633

Review 2.  MicroRNAs as a potential tool in the differential diagnosis of thyroid cancer: a systematic review and meta-analysis.

Authors:  Wei-Jun Wei; Chen-Tian Shen; Hong-Jun Song; Zhong-Ling Qiu; Quan-Yong Luo
Journal:  Clin Endocrinol (Oxf)       Date:  2015-02-12       Impact factor: 3.478

3.  Down-regulation of MicroRNA-381 promotes cell proliferation and invasion in colon cancer through up-regulation of LRH-1.

Authors:  Yan Liang; Qun Zhao; Liqiao Fan; Zhidong Zhang; Bibo Tan; Yu Liu; Yong Li
Journal:  Biomed Pharmacother       Date:  2015-08-28       Impact factor: 6.529

4.  miR-381, a novel intrinsic WEE1 inhibitor, sensitizes renal cancer cells to 5-FU by up-regulation of Cdc2 activities in 786-O.

Authors:  Binghai Chen; Lujing Duan; Guangming Yin; Jing Tan; Xianzhen Jiang
Journal:  J Chemother       Date:  2013-05-07       Impact factor: 1.714

5.  Inhibition of long non-coding RNA TUG1 on gastric cancer cell transference and invasion through regulating and controlling the expression of miR-144/c-Met axis.

Authors:  Ting-Ting Ji; Xuan Huang; Jie Jin; Sheng-Hua Pan; Xiao-Ju Zhuge
Journal:  Asian Pac J Trop Med       Date:  2016-03-23       Impact factor: 1.226

6.  MiR-381 inhibits epithelial ovarian cancer malignancy via YY1 suppression.

Authors:  Bairong Xia; Huiyan Li; Shanshan Yang; Tianbo Liu; Ge Lou
Journal:  Tumour Biol       Date:  2016-01-14

Review 7.  Epithelial-mesenchymal transition in tumor metastasis.

Authors:  Kay T Yeung; Jing Yang
Journal:  Mol Oncol       Date:  2016-12-09       Impact factor: 6.603

8.  Upregulation of microRNA-181b inhibits CCL18-induced breast cancer cell metastasis and invasion via the NF-κB signaling pathway.

Authors:  Lei Wang; Yu-Xia Wang; Li-Ping Chen; Ming-Li Ji
Journal:  Oncol Lett       Date:  2016-10-05       Impact factor: 2.967

9.  miR-381 suppresses C/EBPα-dependent Cx43 expression in breast cancer cells.

Authors:  Jia Ming; Yan Zhou; Junze Du; Shenghao Fan; Beibei Pan; Yinhuan Wang; Lingjun Fan; Jun Jiang
Journal:  Biosci Rep       Date:  2015-10-08       Impact factor: 3.840

10.  Basic fibroblast growth factor promotes VEGF-C-dependent lymphangiogenesis via inhibition of miR-381 in human chondrosarcoma cells.

Authors:  Huey-En Tzeng; An-Chen Chang; Chun-Hao Tsai; Shih-Wei Wang; Chih-Hsin Tang
Journal:  Oncotarget       Date:  2016-06-21
View more
  13 in total

Review 1.  Role of taurine, its haloamines and its lncRNA TUG1 in both inflammation and cancer progression. On the road to therapeutics? (Review).

Authors:  Stella Baliou; Anthony M Kyriakopoulos; Demetrios A Spandidos; Vassilios Zoumpourlis
Journal:  Int J Oncol       Date:  2020-07-14       Impact factor: 5.650

2.  MicroRNA-1294 inhibits the proliferation and enhances the chemosensitivity of glioma to temozolomide via the direct targeting of TPX2.

Authors:  Hua Chen; Liang Liu; Xiaojian Li; Yan Shi; Ning Liu
Journal:  Am J Cancer Res       Date:  2018-02-01       Impact factor: 6.166

3.  Clinical value of peripheral blood microRNA detection in evaluation of SOX regimen as neoadjuvant chemotherapy for gastric cancer.

Authors:  Bibo Tan; Yong Li; Yan Di; Liqiao Fan; Qun Zhao; Qingwei Liu; Dong Wang; Nan Jia
Journal:  J Clin Lab Anal       Date:  2017-11-23       Impact factor: 2.352

Review 4.  Clinical crosstalk between microRNAs and gastric cancer (Review).

Authors:  Jing Ouyang; Zhizhong Xie; Xiaoyong Lei; Guotao Tang; Runliang Gan; Xiaoyan Yang
Journal:  Int J Oncol       Date:  2021-03-02       Impact factor: 5.650

5.  miR‑381 functions as a tumor suppressor by targeting ETS1 in pancreatic cancer.

Authors:  Guanen Qiao; Jing Li; Jun Wang; Zhaoyang Wang; Wei Bian
Journal:  Int J Mol Med       Date:  2019-05-23       Impact factor: 4.101

Review 6.  MicroRNA-381-A Key Transcriptional Regulator: Its Biological Function and Clinical Application Prospects in Cancer.

Authors:  Xue Zeng; Zhe Cao; Wenhao Luo; Lianfang Zheng; Taiping Zhang
Journal:  Front Oncol       Date:  2020-11-26       Impact factor: 6.244

7.  ALKBH2 inhibition alleviates malignancy in colorectal cancer by regulating BMI1-mediated activation of NF-κB pathway.

Authors:  Bingxin Ke; Kejun Ye; Shaobing Cheng
Journal:  World J Surg Oncol       Date:  2020-12-10       Impact factor: 2.754

8.  miR-3189-3p Mimics Enhance the Effects of S100A4 siRNA on the Inhibition of Proliferation and Migration of Gastric Cancer Cells by Targeting CFL2.

Authors:  Yue Bian; Junfu Guo; Linlin Qiao; Xiuju Sun
Journal:  Int J Mol Sci       Date:  2018-01-13       Impact factor: 5.923

9.  Long non‑coding RNA NNT‑AS1 knockdown represses the progression of gastric cancer via modulating the miR‑142‑5p/SOX4/Wnt/β‑catenin signaling pathway.

Authors:  Jianfeng Zhang; Kai Zhang; Yingkui Hou
Journal:  Mol Med Rep       Date:  2020-05-18       Impact factor: 2.952

10.  miR-381-3p suppresses breast cancer progression by inhibition of epithelial-mesenchymal transition.

Authors:  Yong-Zheng Yu; Qiang Mu; Qian Ren; Li-Juan Xie; Qi-Tang Wang; Cui-Ping Wang
Journal:  World J Surg Oncol       Date:  2021-08-06       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.